Latest Warrants News

AuMEGA Metals has announced a C$5.35 million capital raising via a flow-through unit offer aimed at advancing its exploration projects in Newfoundland and Labrador. The offer includes shares and warrants, targeting Canadian charity investors with tax incentives.

Nova Minerals has signed a Scheme Implementation Deed to redomicile to the US, aiming for a primary NYSE listing while retaining a secondary ASX listing via CDIs. The move seeks to align corporate structure with its Alaskan operations and enhance access to US capital markets.

GoldArc Resources has confirmed new high-grade gold mineralisation at its Leonora South project, with standout assay results from maiden drilling at Woodpecker, Whistler, and Niagara West. The company is gearing up for extensive follow-up drilling to expand these promising discoveries.

MFF Capital Investments reported a strong half-year net profit of $209.7 million and declared a fully franked interim dividend of 10 cents per share, signaling confidence despite global economic headwinds. The company’s portfolio remains liquid and focused on high-quality holdings as it navigates geopolitical and technological challenges.

Manuka Resources has locked in a US$30 million senior secured loan facility with Nebari to refinance debt and fund production at its Wonawinta and Canbelego mines, positioning itself to capitalise on the current precious metals cycle.

Cosmos Exploration Limited has voluntarily suspended its shares from ASX trading as it prepares to announce significant developments involving an Option Agreement and a capital Placement.

Catalina Resources has reported a significant gold discovery at its Yerilgee Project in Western Australia, intersecting 48 metres at 2.61 grams per tonne from just 15 metres depth. This initial assay confirms a robust mineralised system with a high-grade core, setting the stage for further exploration.

Radiopharm Theranostics reported a 44% increase in net loss to $27 million for the half-year ended December 2025, driven by expanded R&D spending. The company bolstered its cash reserves through a $35 million placement while progressing multiple clinical trials across its radiopharmaceutical pipeline.

Elanor Investors Group reported a $24.5 million net loss for the half year to December 2024, grappling with debt covenant breaches and defaults. The group has struck a $125 million recapitalisation agreement with Rockworth Capital Partners to stabilise its balance sheet and pursue growth.

MinRex Resources Limited (ASX: MRR) has announced a definitive agreement to acquire 100% of Electrum Discovery Corp. (TSX-V: ELY) via a statutory Plan of Arrangement, creating a combined ASX-listed gold-copper exploration company with significant assets in Serbia and Australia.

Vectus Biosystems reports a narrowed half-year loss as it advances clinical drug VB0004 and nears a key asset sale to XORTX Therapeutics.

COG Financial Services reported solid half-year results with an 8% rise in underlying revenue and a 14% increase in profit after tax, driven by acquisitions and expanded equity stakes. The company also announced a fully franked interim dividend of 3.5 cents per share.